• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Saturday 09/23/2017
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Medical

  • 3:55 PM

    SAN DIEGO, January 13, 2016, RGBP /PRNewswire/ — Regen BioPharma Inc. (OTCBB: RGBP) and (PINK: RGBP) provided the following update for its shareholders: Dear Shareholders, As we have now moved into 2016, I would like to take a moment to discuss Regen BioPharma’s overall progress during the last 12 months.  It is of note that Regen’s goal is to make a difference in the health of patients’ lives, particularly those suffering from cancer and disorders of the bone marrow.  By

    Read more
  • 3:50 PM

    MELBOURNE, Australia, Jan. 13, 2016, PPCH, /PRNewswire/ — Propanc Health Group Corporation (OTCQB: PPCH) (“Propanc” or “the Company”), an emerging healthcare company focusing on development of new and proprietary treatments for cancer patients suffering from pancreatic, ovarian and colorectal cancers, today announced the Company received a further $525,000 tranche from an institutional investor in order to progress their lead product, PRP, towards human trials. To date, the Company has received approximately $2.4 Million from the Institutional Investor since the Securities

    Read more
  • 7:37 PM

    ORLANDO, FL, IMUN, / ACCESSWIRE / Immune Therapeutics Inc. (OTCQB: IMUN) CEO, Noreen Griffin, will be making a presentation at today’s JP Morgan Health Conference at the Fairmont hotel in San Francisco. Her 30 minute presentation, which begins at 3:30 p.m. PST, will provide an overview of the company’s major 2015 milestones and will include the outlook for 2016. Immune Therapeutics will showcase the Company’s groundbreaking treatments for cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and autoimmune diseases, and

    Read more
  • 3:10 PM

    Jan 12, 2016, GTHP OTC Disclosure & News Service – Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced today fourth quarter sales revenue for the LuViva® Advanced Cervical Scan was the highest since the launch of the product. LuViva product revenue was approximately $276,000 for the fourth quarter of 2015 versus approximately $183,000 for the same period of 2014, an increase of about 51%. Total sales for

    Read more
  • 3:56 PM

    SOUTH EASTON, Mass., Jan. 11, 2016, PBIO, /PRNewswire/ — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale of broadly enabling, pressure cycling technology (“PCT”)-based sample preparation solutions to the worldwide life sciences industry, today announced it has exceeded its $5 million PIPE goal following the receipt of $255,000 in gross proceeds from the fifth closing of its $5 million Private Placement (the “Offering”). This closing increased the total amount raised in the

    Read more
  • Ani Pharmaceuticals
    4:19 PM

    – NDA #008975 Purified Cortrophin Gel, 40 units/mL and 80 units/mL – NDA #009854 Cortrophin-Zinc hydroxide, 40 units/mL BAUDETTE, Minn., Jan. 5, 2016, ANIP, /PRNewswire/ — ANI Pharmaceuticals, Inc. (“ANI”) (NASDAQ: ANIP) today announced that it has completed the acquisition of the NDAs for purified corticotropin gel and corticotropin zinc hydroxide from Merck (known as MSD outside of the United States and Canada) for $75 million in cash and a percentage of future net sales. The acquisition was funded through

    Read more
Public Wire Banner